Cardiac amyloidosis and the use of diuretic and ACE inhibitor therapy in severe heart failure

International Journal of Clinical Practice

Volumn 51, Issue 6, 1997, Pages 384-385

  Nash, K L ^a   Brij, S O ^a   Clesham, G J ^a,b  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b PAPWORTH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; VASODILATOR AGENT;

AGED; ARTICLE; CASE REPORT; ELECTROCARDIOGRAPHY; HEART AMYLOIDOSIS; HEART FAILURE; HUMAN; HYPOTENSION; MALE; PRIORITY JOURNAL; PROGNOSIS;

AGED; AMYLOIDOSIS; CAPTOPRIL; CARDIOMYOPATHIES; DIURETICS; FATAL OUTCOME; HEART FAILURE, CONGESTIVE; HUMANS; MALE;

EID: 0030794792     PISSN: 13685031     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. SOLVD Investigators. Effect of enalapril on survival in patients with reduced ejection fraction and congestive heart failure. N Eng J Med 1991; 325: 293-302.
2. Cohn JN, Johnson G, Ziesche S et al. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Eng J Med 1991; 325: 303-310.
3. Cueto-Garcia L, Reeder GS, Kyle RA et al. Echocardiographic findings in systemic amyloidosis: spectrum of cardiac involvement and relation to survival. J Am Coll Cardiol 1985; 6: 737-743.
4. Hamer JPM, Janssen S, van Rijswick MH, Lie KI. Amyloid cardiomyopathy in systemic non-hereditary amyloidosis. Eur Heart J 1992; 13: 623-627.
5. Hall R, Hawkins PN. Cardiac transplantation for AL amyloidosis. BMJ 1994; 309: 1135-1137.